Development and caracterization, bench scale, pegylated liposomal formulation containing the anticancer drug doxorubicin

• Grant number: 17/10754-3
• Support Opportunities: Scholarships in Brazil - Innovative Research in Small Business - PIPE
• Start date: June 01, 2017
• End date: January 31, 2018
• Field of knowledge: Health Sciences - Pharmacy - Pharmaceutical Technology
• Principal Investigator: Alessandra Franco Novelli
• Grantee: Alessandra Franco Novelli
• Company: TS Pharma Soluções Farmacêuticas Ltda. - ME
• Associated research grant: 16/15120-0 - Development and caracterization, bench scale, pegylated liposomal formulation containing the anticancer drug doxorubicin, AP.PIPE